Stoke Therapeutics Inc (NASDAQ:STOK) price on Friday, July 25, fall -3.03% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.1.
A look at the stock’s price movement, the close in the last trading session was $13.51, moving within a range at $12.58 and $13.45. The beta value (5-Year monthly) was 1.142 while the PE ratio in trailing twelve months stood at 16.65. Turning to its 52-week performance, $16.15 and $5.35 were the 52-week high and 52-week low respectively. Overall, STOK moved 10.92% over the past month.
Stoke Therapeutics Inc’s market cap currently stands at around $715.22 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that STOK is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend STOK as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
STOK’s current price about 6.80% and 16.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.53, while 7-day volatility ratio is 9.44% and 5.95% in the 30-day chart. Further, Stoke Therapeutics Inc (STOK) has a beta value of 1.16. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $18 and high of $58. Looking at the price targets, the low is -37.4% off current price level while to achieve the yearly target high, price needs to move -342.75%. Nonetheless, investors will most likely welcome a -67.94% jump to $22 which is the analysts’ median price.
If we refocus on Stoke Therapeutics Inc (NASDAQ:STOK), historical trading data shows that trading volumes averaged 1.01 over the past 10 days and 678.34K over the past 3 months. The company’s latest data on shares outstanding shows there are 54.60 million shares.
The 16.02% of Stoke Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 98.03% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.5 million on 2025-07-15, giving us a short ratio of 20.19. The data shows that as of 2025-07-15 short interest in Stoke Therapeutics Inc (STOK) stood at 2548.0000000000005 of shares outstanding, with shares short falling to 12.11 million registered in 2025-06-13. Current price change has pushed the stock -10.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the STOK stock continues to rise going into the next quarter.
